News Image

NASDAQ:LNTH stands out as a growth opportunity that won't break the bank.

By Mill Chart

Last update: Feb 16, 2024

Take a closer look at LANTHEUS HOLDINGS INC (NASDAQ:LNTH), an affordable growth stock uncovered by our stock screener. NASDAQ:LNTH boasts strong growth prospects and excels in financial health indicators, all while maintaining a reasonable valuation. Let's break it down further.

A Closer Look at Growth for NASDAQ:LNTH

ChartMill assigns a proprietary Growth Rating to each stock. The score is computed by evaluating various growth aspects, like EPS and revenue growth. We take into account the history as well as the estimated future numbers. NASDAQ:LNTH was assigned a score of 8 for growth:

  • The Earnings Per Share has grown by an impressive 88.71% over the past year.
  • Measured over the past years, LNTH shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.91% on average per year.
  • LNTH shows a strong growth in Revenue. In the last year, the Revenue has grown by 50.42%.
  • Measured over the past years, LNTH shows a very strong growth in Revenue. The Revenue has been growing by 23.06% on average per year.
  • Based on estimates for the next years, LNTH will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.38% on average per year.
  • LNTH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.46% yearly.

Understanding NASDAQ:LNTH's Valuation

ChartMill assigns a Valuation Rating to every stock. This score ranges from 0 to 10 and evaluates the different valuation aspects and compares the price to earnings and cash flows, while taking into account profitability and growth. NASDAQ:LNTH scores a 9 out of 10:

  • The Price/Earnings ratio is 9.87, which indicates a very decent valuation of LNTH.
  • Compared to the rest of the industry, the Price/Earnings ratio of LNTH indicates a rather cheap valuation: LNTH is cheaper than 97.47% of the companies listed in the same industry.
  • LNTH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.56.
  • Based on the Price/Forward Earnings ratio of 9.07, the valuation of LNTH can be described as reasonable.
  • LNTH's Price/Forward Earnings ratio is rather cheap when compared to the industry. LNTH is cheaper than 98.48% of the companies in the same industry.
  • LNTH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.62.
  • Based on the Enterprise Value to EBITDA ratio, LNTH is valued cheaply inside the industry as 85.35% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, LNTH is valued cheaper than 96.46% of the companies in the same industry.
  • LNTH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of LNTH may justify a higher PE ratio.
  • A more expensive valuation may be justified as LNTH's earnings are expected to grow with 15.08% in the coming years.

Evaluating Health: NASDAQ:LNTH

Every stock is evaluated by ChartMill, receiving a Health Rating on a scale of 0 to 10. This assessment considers different health aspects, including liquidity and solvency, both in absolute terms and relative to industry peers. NASDAQ:LNTH has achieved a 7 out of 10:

  • LNTH has an Altman-Z score of 4.72. This indicates that LNTH is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 4.72, LNTH is doing good in the industry, outperforming 76.26% of the companies in the same industry.
  • The Debt to FCF ratio of LNTH is 2.17, which is a good value as it means it would take LNTH, 2.17 years of fcf income to pay off all of its debts.
  • LNTH has a Debt to FCF ratio of 2.17. This is amongst the best in the industry. LNTH outperforms 90.40% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for LNTH, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
  • LNTH has a Current Ratio of 5.37. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
  • LNTH has a Current ratio of 5.37. This is in the better half of the industry: LNTH outperforms 70.20% of its industry peers.
  • A Quick Ratio of 5.05 indicates that LNTH has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 5.05, LNTH is in the better half of the industry, outperforming 74.24% of the companies in the same industry.

Profitability Insights: NASDAQ:LNTH

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NASDAQ:LNTH has achieved a 7:

  • LNTH has a better Return On Assets (6.84%) than 86.87% of its industry peers.
  • The Return On Equity of LNTH (14.90%) is better than 90.91% of its industry peers.
  • LNTH has a Return On Invested Capital of 11.01%. This is amongst the best in the industry. LNTH outperforms 92.42% of its industry peers.
  • LNTH has a Profit Margin of 8.63%. This is amongst the best in the industry. LNTH outperforms 83.84% of its industry peers.
  • With an excellent Operating Margin value of 15.55%, LNTH belongs to the best of the industry, outperforming 87.88% of the companies in the same industry.
  • The Gross Margin of LNTH (63.31%) is better than 65.66% of its industry peers.
  • In the last couple of years the Gross Margin of LNTH has grown nicely.

Every day, new Affordable Growth stocks can be found on ChartMill in our Affordable Growth screener.

Check the latest full fundamental report of LNTH for a complete fundamental analysis.

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

LANTHEUS HOLDINGS INC

NASDAQ:LNTH (4/19/2024, 7:01:46 PM)

After market: 63.81 0 (0%)

63.81

+1.48 (+2.37%)

LNTH News

News Image2 days ago - Lantheus Holdings, Inc.Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
News Image2 days ago - Lantheus Holdings, Inc.Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time

BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference...

News Image3 days ago - ChartmillNASDAQ:LNTH: a strong growth stock preparing for the next leg up?.

LANTHEUS HOLDINGS INC (NASDAQ:LNTH) qualifies as a high growth stock and is consolidating.

News Image8 days ago - The Motley Fool2 Magnificent Stocks You Probably Never Heard Of

You might not have heard of these stocks, but they're worth putting on your radar.

News Image9 days ago - ChartmillInvestors should take notice of NASDAQ:LNTH—it offers a great deal for the fundamentals it presents.

LANTHEUS HOLDINGS INC (NASDAQ:LNTH), an undervalued stock with good fundamentals.

News Image9 days ago - InvestorPlaceWall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for April 2024

Explore three Russell 2000 stocks with strong buy ratings for April 2024, offering high growth potential and lower valuations.

News Image18 days ago - Market News VideoInteresting LNTH Put And Call Options For May 17th
News Image18 days ago - ChartmillNASDAQ:LNTH is showing good growth, while it is not too expensive.

Investors seeking growth at a reasonable cost should explore NASDAQ:LNTH.

News Imagea month ago - InvestorPlaceThe 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

Wager on these top undervalued mid-cap stocks, effectively blending growth and value, with a remarkable broader-market performance in 2023.

News Image2 months ago - Lantheus Holdings, Inc.Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024
News Image2 months ago - Lantheus Holdings, Inc.Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024

BEDFORD, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company...

News Image2 months ago - Lantheus Holdings, Inc.Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients

DEFINITY is the #1 utilized ultrasound enhancing agent in the U.S. for patients with suboptimal echocardiograms

LNTH Links
Follow us for more